Literature DB >> 22416256

Early IL-10 production is essential for syngeneic graft acceptance.

Tatiana Takiishi1, Carlos Eduardo Tadokoro, Luiz Vicente Rizzo, Luciana Vieira de Moraes.   

Abstract

We performed a comparative study and evaluated cellular infiltrates and anti-inflammatory cytokine production at different time-points after syngeneic or allogeneic skin transplantation. We observed an early IL-10 production in syngeneic grafts compared with allografts. This observation prompted us to investigate the role of IL-10 in isograft acceptance. For this, we used IL-10 KO and WT mice to perform syngeneic transplantation, where IL-10 was absent in the graft or in the recipient. The majority of syngeneic grafts derived from IL-10 KO donors did not engraft or was only partially accepted, whereas IL-10 KO mice transplanted with skin from WT donors accepted the graft. We evaluated IL-10 producers in the transplanted skin and observed that epithelial cells were the major source. Taken together, our data show that production of IL-10 by donor cells, but not by the recipient, is determinant for graft acceptance and strongly suggest that production of this cytokine by keratinocytes immediately upon transplantation is necessary for isograft survival.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22416256     DOI: 10.1189/jlb.1111569

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  3 in total

1.  Editorial: protean effects of IL-10 include skin self-defense.

Authors:  Daniel H Fowler
Journal:  J Leukoc Biol       Date:  2012-08       Impact factor: 4.962

2.  Interleukin-10-mediated regenerative postnatal tissue repair is dependent on regulation of hyaluronan metabolism via fibroblast-specific STAT3 signaling.

Authors:  Swathi Balaji; Xinyi Wang; Alice King; Louis D Le; Sukanta S Bhattacharya; Chad M Moles; Manish J Butte; Vinicio A de Jesus Perez; Kenneth W Liechty; Thomas N Wight; Timothy M Crombleholme; Paul L Bollyky; Sundeep G Keswani
Journal:  FASEB J       Date:  2016-11-30       Impact factor: 5.191

3.  March1-dependent modulation of donor MHC II on CD103+ dendritic cells mitigates alloimmunity.

Authors:  Thiago J Borges; Naoka Murakami; Felipe D Machado; Ayesha Murshid; Benjamin J Lang; Rafael L Lopes; Laura M Bellan; Mayuko Uehara; Krist H Antunes; Maria José Pérez-Saéz; Gabriel Birrane; Priscila Vianna; João Ismael B Gonçalves; Rafael F Zanin; Jamil Azzi; Reza Abdi; Satoshi Ishido; Jeoung-Sook Shin; Ana Paula D Souza; Stuart K Calderwood; Leonardo V Riella; Cristina Bonorino
Journal:  Nat Commun       Date:  2018-08-28       Impact factor: 14.919

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.